Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

MediWound (MDWD) EBITDA Margin: 2013-2025

Historic EBITDA Margin for MediWound (MDWD) over the last 13 years, with Sep 2025 value amounting to -49.01%.

  • MediWound's EBITDA Margin rose 18724.00% to -49.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 28.85%, marking a year-over-year increase of 10725.00%. This contributed to the annual value of -149.43% for FY2024, which is 11342.00% down from last year.
  • MediWound's EBITDA Margin amounted to -49.01% in Q3 2025, which was down 120.99% from 233.51% recorded in Q2 2025.
  • MediWound's EBITDA Margin's 5-year high stood at 233.51% during Q2 2025, with a 5-year trough of -236.26% in Q3 2024.
  • Its 3-year average for EBITDA Margin is -33.20%, with a median of -45.83% in 2023.
  • Its EBITDA Margin has fluctuated over the past 5 years, first crashed by 19,042bps in 2024, then spiked by 18,724bps in 2025.
  • Over the past 5 years, MediWound's EBITDA Margin (Quarterly) stood at -75.71% in 2021, then skyrocketed by 1,135bps to -64.36% in 2022, then spiked by 3,150bps to -32.86% in 2023, then plummeted by 3,399bps to -66.85% in 2024, then soared by 18,724bps to -49.01% in 2025.
  • Its EBITDA Margin was -49.01% in Q3 2025, compared to 233.51% in Q2 2025 and -18.33% in Q1 2025.